LETTER TO PRESIDENT DONALD J. TRUMP
President Donald J. Trump
The White House
1600 Pennsylvania Avenue NW October 12, 2017
Washington, DC 20500
My name is Dr. Emanuel Sorge, Chairman of Brittle Diabetes Foundation (BDF) and father to a daughter diagnosed five years ago with Brittle Type 1 Diabetes (BT1D). BDF employs an educational website and serves as a resource to an estimated 4,500 Americans and 200,000 worldwide afflicted with this very rare disease.
Sir, if you truly wish to drain the swamp, we would recommend you begin with the NIH and appoint an administrator who can answer the question -Is it a disease or isn’t it? - before spending billions on research that generates useless information.
Here are two reasons why BDF believes you can cut 16 billion dollars per year from the National Institutes of Health (NIH) budget without affecting agency production:
1. Director Dr. Francis Collins, in a public You Tube video released 9/16/2016, https://www.youtube.com/watch?v=cPF7gGbCuWQ paints a picture of a mismanaged agency when he notes that 1/3 of all government funded clinical research trials never register or publish or report their findings on the clinicaltrials.gov website. What he doesn’t tell you is the number of registered trials that never post their results or terminate the study after the clinical trial ends without explanation. Of the 14 Brittle Diabetes registered studies, only two, of nine completed, offer results; three, having been terminated without explanation.
2.And, The findings of Dr. John P.A. Ioannidis M.D, from Stanford School of Medicine and his colleagues that 85% of the billions spent each year on medical research is wasted because of poor grant research design which leads to wrong conclusions and useless information. In our own research on BT1D, at least 50% of the research papers were based on flawed design (not following the scientific method) leading to what you would call Mr. President, “Fake Results”.
What BDF proposes is the elimination of useless information by the development of trained reviewers to oversee grant design of submissions to the NIH starting with the NIDDK”s Division of Diabetes, thereby eliminating those grants and/or clinical trials with design flaws. The savings would be in the billions and the data achieved, factual and useful.
Dr. Collins was appointed by President Obama in 2009. As an administrator, it took Dr. Collins seven years to come to the realization, that accountability is required when giving away taxpayer monies.
I hear Dr. Collins is loved by senators on both sides of the aisle. Who wouldn’t be when you have a 33 billion dollar budget, the bulk of which is apparently a giveaway program with no accountability on what, if any, outcome is realized.
Mr. President it’s time to end this giveaway of taxpayer money and bring sanity back into the medical profession.
Sir I have attached an addendum, that explains how Brittle Diabetes Foundation’s interaction with the NIH and the American Diabetes Association brought us to this point.
Thank you for listening. God Bless
Emanuel V. Sorge Ph.D. Chairman/BDF
Eric D. Hargan, Acting U.S. Secretary of Health and Human Services
Dr. Francis Collins M.D. Ph.D. Director National Institutes of Health
Dr. Petra Kaufmann M.D., M.Sc. Director Office of Rare Diseases (ORDR)
Dr. Anne Pariser M.D. Deputy Director ORDR
Dr. Griffin P. Rodgers M.D. ,M.A.C.P. Director NIDDK
Dr. Judith Fradkin M.D. Director Division of Diabetes, Endocrinology, & Metabolic Disease